Pharmaniaga Bhd (KLSE:7081) — Market Cap & Net Worth
Market Cap & Net Worth: Pharmaniaga Bhd (7081)
Pharmaniaga Bhd (KLSE:7081) has a market capitalization of $404.98 Million (RM1.61 Billion) as of July 8, 2026. Listed on the KLSE stock exchange, this Malaysia-based company holds position #13421 globally and #145 in its home market, demonstrating a 4.24% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Pharmaniaga Bhd's stock price RM1.23 by its total outstanding shares 1311404895 (1.31 Billion). See Pharmaniaga Bhd (7081) reinvestment ratio to understand how much of operating cash flow is reinvested back into capital assets.
Pharmaniaga Bhd Market Cap History: 2015 to 2026
Pharmaniaga Bhd's market capitalization history from 2015 to 2026. Data shows growth from $295.34 Million to $404.98 Million (2.77% CAGR).
Pharmaniaga Bhd Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Pharmaniaga Bhd's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
0.02x
Pharmaniaga Bhd's market cap is 0.02 times its annual revenue
Latest Price to Earnings (P/E) Ratio
1.93x
Pharmaniaga Bhd's market cap is 1.93 times its annual earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2016 | $254.94 Million | $2.19 Billion | $45.60 Million | 0.12x | 5.59x |
| 2017 | $229.75 Million | $2.32 Billion | $53.82 Million | 0.10x | 4.27x |
| 2018 | $147.01 Million | $2.38 Billion | $42.47 Million | 0.06x | 3.46x |
| 2019 | $113.53 Million | $2.82 Billion | -$149.22 Million | 0.04x | N/A |
| 2020 | $284.57 Million | $2.73 Billion | $27.49 Million | 0.10x | 10.35x |
| 2021 | $222.15 Million | $4.82 Billion | $172.15 Million | 0.05x | 1.29x |
| 2022 | $179.44 Million | $3.48 Billion | -$629.92 Million | 0.05x | N/A |
| 2023 | $126.76 Million | $3.40 Billion | -$80.16 Million | 0.04x | N/A |
| 2024 | $116.88 Million | $3.76 Billion | $131.82 Million | 0.03x | 0.89x |
| 2025 | $93.84 Million | $3.93 Billion | $48.51 Million | 0.02x | 1.93x |
Competitor Companies of 7081 by Market Capitalization
Companies near Pharmaniaga Bhd in the global market cap rankings as of July 8, 2026.
Key companies related to Pharmaniaga Bhd by market ranking:
- McKesson Corporation (NYSE:MCK): Ranked #266 globally with a market cap of $94.27 Billion USD.
- Cencora Inc. (NYSE:COR): Ranked #533 globally with a market cap of $50.53 Billion USD.
- Cardinal Health Inc (NYSE:CAH): Ranked #634 globally with a market cap of $43.01 Billion USD.
- Sigma Healthcare Ltd (AU:SIG): Ranked #1147 globally with a market cap of $23.03 Billion USD ( AU$32.55 Billion AUD).
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #266 | McKesson Corporation | NYSE:MCK | $94.27 Billion | $784.23 |
| #533 | Cencora Inc. | NYSE:COR | $50.53 Billion | $298.55 |
| #634 | Cardinal Health Inc | NYSE:CAH | $43.01 Billion | $237.52 |
| #1147 | Sigma Healthcare Ltd | AU:SIG | $23.03 Billion | AU$2.82 |
Pharmaniaga Bhd Historical Marketcap From 2015 to 2026
Between 2015 and today, Pharmaniaga Bhd's market cap moved from $295.34 Million to $ 404.98 Million, with a yearly change of 2.77%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | RM404.98 Million | +331.58% |
| 2025 | RM93.84 Million | -19.72% |
| 2024 | RM116.88 Million | -7.79% |
| 2023 | RM126.76 Million | -29.36% |
| 2022 | RM179.44 Million | -19.22% |
| 2021 | RM222.15 Million | -21.94% |
| 2020 | RM284.57 Million | +150.67% |
| 2019 | RM113.53 Million | -22.78% |
| 2018 | RM147.01 Million | -36.01% |
| 2017 | RM229.75 Million | -9.88% |
| 2016 | RM254.94 Million | -13.68% |
| 2015 | RM295.34 Million | -- |
End of Day Market Cap According to Different Sources
On Jul 7th, 2026 the market cap of Pharmaniaga Bhd was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $404.98 Million USD |
| MoneyControl | $404.98 Million USD |
| MarketWatch | $404.98 Million USD |
| marketcap.company | $404.98 Million USD |
| Reuters | $404.98 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About Pharmaniaga Bhd
Pharmaniaga Berhad, an investment holding company, operates as an integrated healthcare service provider in Malaysia, Indonesia, and internationally. The company operates through Logistics and Distribution, Manufacturing, and Indonesia segments. It is involved in manufacturing, distribution, and marketing of pharmaceutical and medical products, such as generic drugs and over-the-counter medicines… Read more